Genetics

Genetics, Anatomy, and the OMENS Classification

At a Glance

Goldenhar syndrome (OAVS) is a congenital condition caused by a disruption in the first and second branchial arches during early fetal development. Doctors use the OMENS+ grading system to evaluate facial features and systemic anomalies, which helps map out a personalized care and treatment plan.

Understanding the biological “why” behind an OAVS diagnosis can help transform a confusing set of symptoms into a clear roadmap for care. Goldenhar Syndrome, or OAVS, is fundamentally a difference in how the face and neck form during the very earliest stages of life.

The Building Blocks: Branchial Arches

In the first few weeks of fetal development, an embryo develops several small folds of tissue called branchial arches (also known as pharyngeal arches). These are the “building blocks” of the face and neck ^[1].

OAVS occurs when there is a disruption in the development of the first and second branchial arches ^[2].

The First Arch: This structure is responsible for forming the upper and lower jaws (mandible and maxilla), the cheekbones, and parts of the palate ^[3].
The Second Arch: This structure contributes to the development of the external and middle ear, as well as the muscles used for facial expressions ^[4].

When these arches don’t develop as expected, it leads to the characteristic features of OAVS, such as facial asymmetry, ear differences, or skin tags ^[5].

Genetics: Why Did This Happen?

The most important thing for parents to know is that nothing you did, ate, or experienced caused this condition.

For the vast majority of individuals, OAVS is sporadic, meaning it happens by chance and does not run in the family ^[3]^[6]. However, researchers are finding that the “blueprint” for facial development is incredibly complex:

Genetic Factors: Scientists have identified specific genes—such as FOXI3, MYT1, and CHAF1A—that play a role in guiding those branchial arches ^[7]^[8]^[9].
Environmental Interactions: Sometimes, a genetic predisposition may interact with environmental factors during development ^[10].

It is important to note that standard clinical genetic tests for OAVS often come back “normal” ^[3]. While we don’t always have a single “smoking gun” gene, genetic testing can sometimes help doctors understand if there is a higher chance of this occurring in future siblings.

The OMENS+ Classification

To help doctors communicate clearly and plan the best care, they use a grading system called OMENS. This is a tool to measure the physical severity of different features—it is not a measure of potential or future happiness.

Each letter stands for a different area the doctor is evaluating:

O (Orbit): The size and position of the eye socket ^[11].
M (Mandible): The size and shape of the lower jaw ^[12].
E (Ear): The shape of the external ear and the presence of any ear tags ^[13].
N (Nerve): How well the facial nerve (the nerve that controls movement) is working ^[11].
S (Soft Tissue): The amount of fat and muscle tissue on that side of the face ^[12].

What does the “+” mean?

The OMENS+ system adds a plus sign to include features outside of the face ^[14]. Doctors have found that individuals with higher (more severe) scores in the facial categories are more likely to also have “extracraniofacial” or systemic features, such as:

Vertebral (spine) differences ^[15].
Heart (cardiovascular) anomalies ^[16].
Kidney (renal) or central nervous system differences ^[15]^[16].

By using this grading system, the care team can decide when it is the right time for interventions and what screenings are needed for internal organs ^[13].

Common questions in this guide

What causes Goldenhar syndrome?

Goldenhar syndrome, or OAVS, occurs due to a disruption in the development of the first and second branchial arches during the early weeks of pregnancy. For the vast majority of cases, it happens completely by chance and is not caused by anything the parents did or experienced.

Is Goldenhar syndrome hereditary?

In most individuals, Goldenhar syndrome is sporadic, meaning it occurs randomly and does not run in the family. While some specific genes have been linked to the condition, standard genetic tests often come back normal.

What does the OMENS classification stand for?

OMENS is a medical grading system used to evaluate the physical severity of Goldenhar syndrome. It stands for Orbit (eye socket), Mandible (lower jaw), Ear, Nerve (facial movement), and Soft tissue.

What does the plus sign in OMENS+ mean?

The plus sign indicates the presence of extracraniofacial features, which are structural differences outside of the face and head. This commonly includes anomalies in the spine, heart, kidneys, or central nervous system.

Why should my child get genetic testing for OAVS?

Even though standard clinical genetic tests for OAVS often return normal results, tests like chromosomal microarrays or exome sequencing can help rule out other conditions. This information helps your medical team better understand your child's specific developmental blueprint and the chances of it occurring in future siblings.

Curated prompts to bring to your next appointment.

1.What are the specific scores in each of the OMENS categories for this case?
2.Based on these scores, what is the current priority for treatment (e.g., jaw growth, hearing support, or eye health)?
3.Given the OMENS scores, what is the risk for extracraniofacial issues in the heart or kidneys?
4.Would genetic testing like a chromosomal microarray or exome sequencing be helpful?
5.How does the OMENS grade influence the timing of future interventions, like jaw distraction?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (16)

1
Description of a family with X-linked oculo-auriculo-vertebral spectrum associated with polyalanine tract expansion in ZIC3.
Trimouille A, Tingaud-Sequeira A, Lacombe D, et al.
Clinical genetics 2020; (98(4)):384-389 doi:10.1111/cge.13811.
PMID: 32639022
2
Oculo-Auriculo-Vertebral Dysplasia With Craniocervical Instability and Occult Tethered Cord Syndrome. An Addition to the Spectrum? First Case Report and Review of the Literature.
Hansen-Algenstaedt N, Liem M, Khalifah S, et al.
Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews 2019; (3(7)):e805 doi:10.5435/JAAOSGlobal-D-17-00085.
PMID: 31579884
3
Oculo-auriculo-vertebral spectrum: clinical and molecular analysis of 51 patients.
Beleza-Meireles A, Hart R, Clayton-Smith J, et al.
European journal of medical genetics 2015; (58(9)):455-65.
PMID: 26206081
4
Goldenhar syndrome associated with lacrimal system agenesis: A case report.
Tam MW, Boyle N
American journal of ophthalmology case reports 2023; (29()):101766 doi:10.1016/j.ajoc.2022.101766.
PMID: 36544754
5
Goldenhar Syndrome - ophthalmologist's perspective.
Schmitzer S, Burcel M, Dăscălescu D, Popteanu IC
Romanian journal of ophthalmology 2018; (62(2)):96-104.
PMID: 30206552
6
Multicorrection Goldenhar syndrome (facio-auriculo-vertebral dysplasia): a rare follow-up case of 12-year-old female.
Varma AR, Meshram RJ, Varma AR, et al.
The Pan African medical journal 2021; (39()):96 doi:10.11604/pamj.2021.39.96.27259.
PMID: 34466198
7
Novel variants in FOXI3 gene confirm its implication in Oculo-Auriculo-Vertebral spectrum.
Sequeira A, Sagardoy T, Bourgeade L, et al.
European journal of human genetics : EJHG 2025; (33(5)):683-687 doi:10.1038/s41431-025-01837-6.
PMID: 40128339
8
Chromatin assembly factor subunit CHAF1A as a monogenic cause for oculo-auriculo-vertebral spectrum.
Pingault V, Neiva-Vaz C, de Oliveira J, et al.
European journal of human genetics : EJHG 2025; (33(1)):131-136 doi:10.1038/s41431-024-01698-5.
PMID: 39333427
9
Mutations in MYT1, encoding the myelin transcription factor 1, are a rare cause of OAVS.
Lopez E, Berenguer M, Tingaud-Sequeira A, et al.
Journal of medical genetics 2016; (53(11)):752-760 doi:10.1136/jmedgenet-2016-103774.
PMID: 27358179
10
OTX2 duplications: a recurrent cause of oculo-auriculo-vertebral spectrum.
Celse T, Tingaud-Sequeira A, Dieterich K, et al.
Journal of medical genetics 2023; (60(6)):620-626 doi:10.1136/jmg-2022-108678.
PMID: 36368868
11
Hemifacial Microsomia Review: Recent Advancements in Understanding the Disease.
Paul MA, Opyrchał J, Knakiewicz M, et al.
The Journal of craniofacial surgery 2020; (31(8)):2123-2127 doi:10.1097/SCS.0000000000006616.
PMID: 33136839
12
Virtual planning for corrections of hemifacial microsomia.
Sugar A, Evans P, Bartlett S, Key S
Innovative surgical sciences 2023; (8(3)):159-183 doi:10.1515/iss-2021-0010.
PMID: 38077487
13
Hemifacial Microsomia: Clinical Features and Associated Anomalies.
Allam KA
The Journal of craniofacial surgery 2021; (32(4)):1483-1486 doi:10.1097/SCS.0000000000007408.
PMID: 33587521
14
Ocular and adnexal anomalies in craniofacial microsomia: Type and prevalence in a multicentre cohort study.
Rooijers W, Renkema RW, Loudon SE, et al.
International journal of oral and maxillofacial surgery 2021; (50(10)):1303-1311 doi:10.1016/j.ijom.2021.02.032.
PMID: 33752938
15
Extracraniofacial anomalies in craniofacial microsomia: retrospective analysis of 991 patients.
Renkema RW, Caron CJJM, Pauws E, et al.
International journal of oral and maxillofacial surgery 2019; (48(9)):1169-1176 doi:10.1016/j.ijom.2019.01.031.
PMID: 30878275
16
Vertebral anomalies in craniofacial microsomia: a retrospective analysis of 991 patients.
Renkema RW, Caron CJJM, Wolvius EB, et al.
International journal of oral and maxillofacial surgery 2018; (47(11)):1365-1372 doi:10.1016/j.ijom.2018.05.016.
PMID: 30722936

This page explains the genetics and OMENS classification of Goldenhar syndrome for educational purposes. Always consult a geneticist or craniofacial specialist for an accurate diagnosis and personalized treatment plan for your child.

Get notified when new evidence is published on Goldenhar syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents